NO20074102L - Rensing av Rapamycin - Google Patents

Rensing av Rapamycin

Info

Publication number
NO20074102L
NO20074102L NO20074102A NO20074102A NO20074102L NO 20074102 L NO20074102 L NO 20074102L NO 20074102 A NO20074102 A NO 20074102A NO 20074102 A NO20074102 A NO 20074102A NO 20074102 L NO20074102 L NO 20074102L
Authority
NO
Norway
Prior art keywords
rapamycin
purification
purified rapamycin
chemical process
obtaining
Prior art date
Application number
NO20074102A
Other languages
English (en)
Norwegian (no)
Inventor
Bogdan Kazimierz Wilk
Warren Chew
Chia-Cheng Shaw
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20074102L publication Critical patent/NO20074102L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20074102A 2005-03-02 2007-08-08 Rensing av Rapamycin NO20074102L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65791005P 2005-03-02 2005-03-02
PCT/US2006/006212 WO2006093745A1 (en) 2005-03-02 2006-02-22 Purification of rapamycin

Publications (1)

Publication Number Publication Date
NO20074102L true NO20074102L (no) 2007-09-26

Family

ID=36568679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074102A NO20074102L (no) 2005-03-02 2007-08-08 Rensing av Rapamycin

Country Status (15)

Country Link
US (1) US7384953B2 (zh)
EP (1) EP1853612A1 (zh)
JP (1) JP2008531686A (zh)
KR (1) KR20070107087A (zh)
CN (1) CN101133065A (zh)
AU (1) AU2006218918A1 (zh)
CA (1) CA2599582A1 (zh)
CR (1) CR9297A (zh)
IL (1) IL185077A0 (zh)
MX (1) MX2007010716A (zh)
NI (1) NI200700225A (zh)
NO (1) NO20074102L (zh)
RU (1) RU2007130406A (zh)
WO (1) WO2006093745A1 (zh)
ZA (1) ZA200707523B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2493878C (en) 2002-07-30 2013-07-23 Wyeth Parenteral formulations containing a rapamycin hydroxyester
EP2079748A4 (en) * 2006-11-10 2011-05-04 Biocon Ltd PURE FORM OF RAPAMYCIN AND ITS RECOVERY AND PURIFICATION PROCESS
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414909B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
JP2012533548A (ja) 2009-07-14 2012-12-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド 組成物における黄色形成および過酸化物形成を阻害する方法
CN102443012B (zh) * 2010-10-13 2016-03-02 鲁南制药集团股份有限公司 一种从发酵液中提纯雷帕霉素的方法
CN103705925B (zh) 2012-09-29 2018-03-30 段磊 抑制PI3K/AKT/mTOR信号通路的药物组合
US9750728B2 (en) 2012-09-29 2017-09-05 Targeted Therapeutics, Llc Method and pharmaceutical composition for inhibiting PI3K/AKT/mTOR signaling pathway
SG10201707632PA (en) 2013-03-15 2017-11-29 Biosensors Int Group Ltd Purification of rapamycin derivatives
CA2926719C (en) 2013-10-08 2020-11-24 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
EP4218742A1 (en) * 2014-04-04 2023-08-02 AI Therapeutics, Inc. An inhalable rapamycin formulation for treating age-related conditions
EP3209330B1 (en) 2014-10-07 2022-02-23 AI Therapeutics, Inc. An inhalable sirolimus formulation for the treatment of pulmonary hypertension
WO2016130645A1 (en) 2015-02-10 2016-08-18 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
WO2018031789A1 (en) 2016-08-10 2018-02-15 The Board Of Regents Of The University Of Texas System Topical rapamycin therapy
CN109369679A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种雷帕霉素的精制方法
CN109369680A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种依维莫司的纯化方法
CN109485657A (zh) * 2018-12-24 2019-03-19 江苏卓和药业有限公司 一种替西罗莫司的纯化方法
TW202045165A (zh) 2019-02-20 2020-12-16 美商Ａｉ治療公司 局部雷帕黴素調配物以及其於治療臉部血管纖維瘤和其他皮膚疾病中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
WO2005010010A1 (en) 2003-07-16 2005-02-03 Wyeth Cci-779 isomer c
KR20060057605A (ko) 2003-08-07 2006-05-26 와이어쓰 Ｃｃｉ-779의 위치선택적 합성 방법

Also Published As

Publication number Publication date
MX2007010716A (es) 2008-01-16
JP2008531686A (ja) 2008-08-14
EP1853612A1 (en) 2007-11-14
CA2599582A1 (en) 2006-09-08
NI200700225A (es) 2008-07-03
AU2006218918A1 (en) 2006-09-08
KR20070107087A (ko) 2007-11-06
CN101133065A (zh) 2008-02-27
US7384953B2 (en) 2008-06-10
US20060199954A1 (en) 2006-09-07
ZA200707523B (en) 2010-02-24
WO2006093745A1 (en) 2006-09-08
CR9297A (es) 2008-01-21
RU2007130406A (ru) 2009-04-10
IL185077A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
NO20074102L (no) Rensing av Rapamycin
TW200639161A (en) Process for the purification of duloxetine hydrochloride
NO20056149L (no) Fremgangsmate og reaktor for produksjon av karbon nanoror
DK2292607T3 (da) Fremgangsmåde til syntese af organiske forbindelser
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DE602004016796D1 (de) Reinigungverfahren für Synthesegas
NL1033051A1 (nl) Productie van koolwaterstoffen uit natuurlijk gas.
NO20041015L (no) Organisk silisium inneholdende blandinger for økning av hydrokarbonproduksjon og fremgangsmåte for anvendelse derav.
DK2057136T3 (da) Fremgangsmåde til syntese og/eller oprensning af diaminophenothiazinium forbindelser
DK1654438T3 (da) Fremgangsmåde til naturgasproduktion
DK3336073T3 (da) Fremgangsmåde til fremstilling af fluorerede organiske forbindelser
DE602005021846D1 (de) Reinigungsverfahren für rohes Trimethylaluminium
GB0620026D0 (en) Organic compound,optical crystal film and method of production thereof
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
NO20064012L (no) Kjemisk prosess
NO20054903D0 (no) Fremgangsmate for rensing av koksverk-avlopsvann med gasspermeabel membran
GT200500350A (es) Proceso de manufactura de compuestos organicos
EP1954649A4 (en) PROCESS FOR PREPARING HYGIENIZED ORGANIC MUD
DK1842908T3 (da) Fremgangsmåde til fremstilling af oprenset lipase
NO20074101L (no) Isolering av CCI-779 fra morvaesker
NO20082379L (no) Fremgangsmate for fremstilling av renset krystallinsk CCI-779
NO20076606L (no) Integrert prosess for behandling av avlopsvann og avgasser fra avlopsvann samt fra behandling av avlopsvann

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application